All material subject to strictly enforced copyright laws. © 2022 Euromoney Institutional Investor PLC group

"Levying additional costs beyond [corporates'] normal credit lines is highly undesirable--not least when for some time we will be trying to achieve a recovery in the real economy."

--Sharon Bowles, chairwoman of the European Parliament's Economic and Monetary Affairs Committee, on why corporates should be exempt from pending over-the-counter derivatives regulation in Europe.

Unlock this article.

The content you are trying to view is exclusive to our subscribers.

To unlock this article:

Take a Free Trial or Login
We use cookies to provide a personalized site experience.
By continuing to use & browse the site you agree to our Privacy Policy.
I agree